Skip to search formSkip to main contentSkip to account menu

pirlindole

Known as: pyrlindole, pirlindol, 1H-Pyrazino(3,2,1-jk)carbazole, 2,3,3a,4,5,6-hexahydro-8-methyl-, monohydrochloride 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
AbstractBackground: Depressive disorders are common health problems. Both preclinical and clinical studies have shown that… 
1998
1998
The interaction with monoamine oxidase A (MAO-A) and B has been shown to be sensitive to the absolute configuration of molecules… 
1997
1996
1996
The efficacy and safety of pirlindole (300 mg/day), a new reversible inhibitor of monoamine oxidase A, have been evaluated in a… 
1989
1989
The reduced speech activity of depressed patients is a consistent finding in many systematic studies. However, this and other… 
1985
1985
In a double-blind placebo-controlled cross-over study the pharmacokinetic and pharmacodynamic properties of acutely and… 
1983
1983
Cardiovascular dynamic, inotropic and electrophysiologic effects of the new tetracyclic antidepressant 2,3,3a,4,5,6-hexahydro-8… 
1982
1982
Utilizing quantitative analysis of the human electroencephalogram (EEG), the effect of typical and atypical antidepressants on… 
1981
1981
The hydrochloride salt of 2,3,3a,4,5,6-hexahydro-8-methyl-1H-pyrazino[3,2,1-j,k]carbazol hydrochloride (pirlindole) exerts…